The role of new technique of theranostics in treating patients suffering from prostrate cancer was discussed at a symposium here today.
Specialist doctors from across the globe participated in the symposium, organised at Rajiv Gandhi Cancer Institute and Research Centre (RGCI&RC).
The technique of theranostics is a combination of diagnostics and therapy, which offers personalised accurate treatment for prostate cancer and neuroendocrine tumors, said Dr Partha S Choudhury, Director, Nuclear Medicine, RGCI&RC.
"The field of theranostics is rapidly facilitating the shift from 'trial and error' medicine to personalised medicine and holds great promise for improved patient outcomes," he said.
Delegates of the symposium were given detailed insight into the specific receptor based imaging of neuroendocrine and prostate tumors in diagnosis, evaluation of treatment response and prognosis during the event, he said.
Current information on the use of these receptor based therapy with radionuclides, its response and treatment outcomes were also discussed, he added.
